Tick-borne encephalitis
Conditions
Brief summary
Concentrations of cytokines detected using our novel rapid release assay (T-cell assay) for TBE in relation to antibody responses (B-cell assays) as measured by commercially available assays.
Detailed description
The duration of detectable T- and B-cell immune responses directed against TBEV after infection with TBE., The duration of detectable T- and B-cell immune responses directed against TBEV after vaccination against TBE., Are cross-reactive T- and B-cell immune responses directed against TBEV detectable after prior vaccination against other flaviviruses, e.g., Yellow Fever and Japanese Encephalitis, and if so, are these responses transient or persistent?
Interventions
DRUGFSME-IMMUN Vuxen
DRUGinjektionsvätska
DRUGsuspension i förfylld spruta Vaccin mot fästingburen encefalit (helvirus inaktiverat)
DRUGEncepur (0
DRUG5 ml)
Injektionsvätska
DRUGsuspension
DRUGi förfylld spruta
Vaccin mot fästingburen encefalit (TBE)
DRUGinaktiverat
Sponsors
Vaestra Goetalandsregionen
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Concentrations of cytokines detected using our novel rapid release assay (T-cell assay) for TBE in relation to antibody responses (B-cell assays) as measured by commercially available assays. | — |
Secondary
| Measure | Time frame |
|---|---|
| The duration of detectable T- and B-cell immune responses directed against TBEV after infection with TBE., The duration of detectable T- and B-cell immune responses directed against TBEV after vaccination against TBE., Are cross-reactive T- and B-cell immune responses directed against TBEV detectable after prior vaccination against other flaviviruses, e.g., Yellow Fever and Japanese Encephalitis, and if so, are these responses transient or persistent? | — |
Countries
Sweden
Outcome results
None listed